Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections

Status unconfirmed · Phase 1

Conditions studied: Cancer

In brief

RATIONALE: White blood cells that have been treated in the laboratory may kill cells that are infected with cytomegalovirus. PURPOSE: This phase I trial is studying how well cytotoxic T cells work in treating patients who have undergone donor stem cell transplant and have cytomegalovirus infections.

Key facts

Study ID

NCT00769613

Run by

Milton S. Hershey Medical Center

People needed

20

Starts

2008-08-01

Last updated by the study team

2013-12-18

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Penn State Cancer Institute at Milton S. Hershey Medical Center — Hershey, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.